Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any autosomal recessive congenital ichthyosis in which the cause of the disease is a mutation in the ABCA12 gene.
Features include always present findings: Congenital nonbullous ichthyosiform erythroderma; and very common findings: Ectropion and Palmoplantar keratoderma. 7 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Skin | 2 | Congenital nonbullous ichthyosiform erythroderma, Palmoplantar keratoderma |
ABCA12 encodes ATP binding cassette subfamily A member 12 (2,595 aa). Transports lipids such as glucosylceramides from the outer to the inner leaflet of lamellar granules (LGs) membrane, whereby the lipids are finally transported to the keratinocyte periphery via the trans-Golgi network and LGs and released to the apical surface of the granular keratinocytes to form lipid lamellae in the stratum corneum of the epidermis, which is essential for skin barrier function. Highest expression in Skin Sun Exposed Lower leg (36.2 TPM) and Skin Not Sun Exposed Suprapubic (32.0 TPM).
Autosomal recessive congenital ichthyosis 4A is associated with mutations in the ABCA12 gene on chromosome 2.
The ABCA12 protein participates in ABCA12 K1671Ifs*4, ABCA12 V2442Sfs*22, and Defective ABCA12 causes ARCI4B pathways.
ABCA12 is classified as a druggable target (Abc Transporter, Druggable Genome, and Transporter categories) with score 0.0.
76 pathogenic variants reported in ABCA12 in ClinVar.
Genetic testing for ABCA12 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for autosomal recessive congenital ichthyosis 4A has been reported in the published literature.
Phenotype severity distribution: 1 always present feature, 2 very common features.
No clinical trials have been registered for autosomal recessive congenital ichthyosis 4A.
5 publications have been identified in PubMed for autosomal recessive congenital ichthyosis 4A. Research spans Basic Science / Preclinical (40%), Diagnostic / Biomarker (20%), and Case Report / Case Series (20%).
Dubot P (2025). [PMID: 38706107](https://pubmed.ncbi.nlm.nih.gov/38706107/). *Journal of inherited metabolic disease*. [Basic Science / Preclinical]
Hino R (2024). [PMID: 39917683](https://pubmed.ncbi.nlm.nih.gov/39917683/). *Frontiers in dental medicine*. [Case Report / Case Series]
Diociaiuti A (2024). [PMID: 38588653](https://pubmed.ncbi.nlm.nih.gov/38588653/). *Dermatology (Basel, Switzerland)*. [Epidemiology / Natural History]
Ho M (2024). [PMID: 38627868](https://pubmed.ncbi.nlm.nih.gov/38627868/). *Human genomics*. [Basic Science / Preclinical]
Zhu L (2024). [PMID: 39748812](https://pubmed.ncbi.nlm.nih.gov/39748812/). *Frontiers in pediatrics*. [Diagnostic / Biomarker]
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 8:42 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Brain and nerves
1 |
Spastic paraplegia |
Pregnancy and birth | 1 | Congenital nonbullous ichthyosiform erythroderma |
Digestive system | 1 | Hepatosplenomegaly |